Literature DB >> 29627929

First cardiac manifestation of hypotonia-cystinuria syndrome.

Mustafa Kılıç1, Ahmet Cevdet Ceylan2, Utku Arman Örün3, Esra Kılıç4.   

Abstract

Hypotonia-cystinuria syndrome is a very rare autosomal recessive contiguous gene deletion syndrome of PREPL and SLC3A1 at 2p21 with neuromuscular and neuroendocrinologic presentation. We report a two-year-six-month-old affected female infant and her five-month-old affected brother with a novel homozygous deletion in SLC3A1 and PREPL gene. Both of siblings had mild facial dysmorphism, hypotonia, feeding problems, failure to thrive, developmental delay. She also had dilated cardiomyopathy which differ from other reported patients. Therefore cardiomyopathy may also be considered one of the features of hypotonia-cystinuria syndrome. With this case report, we present cardiac manifestation of hypotonia-cystinuria syndrome for the first time. Because of two siblings had hyperechogenic bowel in prenatal sonography, it might be a prenatal marker for HCS.

Entities:  

Keywords:  Developmental delay; Growth failure; Hypotonia-cystinuria syndrome; Non-compaction; PREPL; SLC3A1

Mesh:

Substances:

Year:  2018        PMID: 29627929     DOI: 10.1007/s11011-018-0226-2

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  16 in total

1.  Evaluation of the pediatric patient with hypotonia: don't forget the hypotonia-cystinuria syndrome!

Authors:  Jaak Jaeken; John Creemers; Luc Régal
Journal:  Dev Med Child Neurol       Date:  2011-12-29       Impact factor: 5.449

2.  PREPL, a prolyl endopeptidase-like enzyme by name only?--Lessons from patients.

Authors:  Kurt Boonen; Luc Régal; Jaak Jaeken; John W M Creemers
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-05       Impact factor: 4.388

3.  A recessive contiguous gene deletion of chromosome 2p16 associated with cystinuria and a mitochondrial disease.

Authors:  R Parvari; I Brodyansky; O Elpeleg; S Moses; D Landau; E Hershkovitz
Journal:  Am J Hum Genet       Date:  2001-08-24       Impact factor: 11.025

4.  Further delineation of genotype-phenotype correlation in homozygous 2p21 deletion syndromes: first description of patients without cystinuria.

Authors:  Deborah Bartholdi; Reza Asadollahi; Beatrice Oneda; Thomas Schmitt-Mechelke; Paolo Tonella; Alessandra Baumer; Anita Rauch
Journal:  Am J Med Genet A       Date:  2013-06-21       Impact factor: 2.802

5.  2p21 Deletions in hypotonia-cystinuria syndrome.

Authors:  Thomas Eggermann; Sabrina Spengler; Andreas Venghaus; Bernd Denecke; Klaus Zerres; Michael Baudis; Regina Ensenauer
Journal:  Eur J Med Genet       Date:  2012-07-17       Impact factor: 2.708

6.  Deletion of PREPL, a gene encoding a putative serine oligopeptidase, in patients with hypotonia-cystinuria syndrome.

Authors:  Jaak Jaeken; Kevin Martens; Inge Francois; Francois Eyskens; Claudine Lecointre; Rita Derua; Sandra Meulemans; Jerry W Slootstra; Etienne Waelkens; Francis de Zegher; John W M Creemers; Gert Matthijs
Journal:  Am J Hum Genet       Date:  2005-11-23       Impact factor: 11.025

7.  Global distribution of the most prevalent deletions causing hypotonia-cystinuria syndrome.

Authors:  Kevin Martens; Inge Heulens; Sandra Meulemans; Marco Zaffanello; David Tilstra; Frederik J Hes; Raoul Rooman; Inge François; Francis de Zegher; Jaak Jaeken; Gert Matthijs; John W M Creemers
Journal:  Eur J Hum Genet       Date:  2007-06-20       Impact factor: 4.246

8.  Two novel deletions in hypotonia-cystinuria syndrome.

Authors:  Luc Régal; Halil Ibrahim Aydin; Anne-Marie Dieltjens; Hilde Van Esch; Inge Francois; Ilyas Okur; Cengiz Zeybek; Sandra Meulemans; Christine Van Mol; Lore Van Bruwaene; Siao-Hann Then; Jaak Jaeken; John Creemers
Journal:  Mol Genet Metab       Date:  2012-06-26       Impact factor: 4.797

9.  Whole exome sequencing of suspected mitochondrial patients in clinical practice.

Authors:  Saskia B Wortmann; David A Koolen; Jan A Smeitink; Lambert van den Heuvel; Richard J Rodenburg
Journal:  J Inherit Metab Dis       Date:  2015-03-04       Impact factor: 4.982

10.  PREPL deficiency: delineation of the phenotype and development of a functional blood assay.

Authors:  Luc Régal; Emma Mårtensson; Isabelle Maystadt; Nicol Voermans; Damien Lederer; Alberto Burlina; María Jesús Juan Fita; A Jeannette M Hoogeboom; Mia Olsson Engman; Tess Hollemans; Meyke Schouten; Sandra Meulemans; Tord Jonson; Inge François; David Gil Ortega; Erik-Jan Kamsteeg; John W M Creemers
Journal:  Genet Med       Date:  2017-07-20       Impact factor: 8.822

View more
  2 in total

1.  Causality between myopathic hypotonia-cystinuria syndrome (HCS) and noncompaction (LVHT) is not compelling.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Metab Brain Dis       Date:  2018-06-24       Impact factor: 3.584

2.  Coexistence of Megaconial Congenital Muscular Dystrophy and Cystinuria: Mimicking Hypotonia-Cystinuria Syndrome.

Authors:  Ilknur Surucu Kara; Ummuhan Oncul; Engin Kose; Husnu Mutlu Turan; Ahmet Cevdet Ceylan; Fatma Tuba Eminoglu
Journal:  Mol Syndromol       Date:  2022-02-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.